Cargando…
Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
In most migraine patients acute therapy is needed. Migraine can be treated either with specific drugs, the triptans and ergot alkaloids, or with NSAIDs. Triptans are a major step foreward in migraine therapy. The therapeutic gain for headache relief is 50% for subcutaneous sumatriptan whereas it is...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476138/ https://www.ncbi.nlm.nih.gov/pubmed/17497267 http://dx.doi.org/10.1007/s10194-007-0373-z |
_version_ | 1782247056721575936 |
---|---|
author | Tfelt-Hansen, Peer |
author_facet | Tfelt-Hansen, Peer |
author_sort | Tfelt-Hansen, Peer |
collection | PubMed |
description | In most migraine patients acute therapy is needed. Migraine can be treated either with specific drugs, the triptans and ergot alkaloids, or with NSAIDs. Triptans are a major step foreward in migraine therapy. The therapeutic gain for headache relief is 50% for subcutaneous sumatriptan whereas it is 30-40% for most oral triptans. After oral triptans sustained pain free is only 30%. There is thus still ample room for improvement of acute therapy in migraine. For tension-type headache there is no specific therapy and it is treated with NSAIDs. Only 17-32% become pain free after these drugs. For attacks of cluster headache oxygen and subcutaneous sumatriptan can be used. Intranasal triptans can be an alternative. |
format | Online Article Text |
id | pubmed-3476138 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-34761382012-11-29 Acute pharmacotherapy of migraine, tension-type headache, and cluster headache Tfelt-Hansen, Peer J Headache Pain Tutorial In most migraine patients acute therapy is needed. Migraine can be treated either with specific drugs, the triptans and ergot alkaloids, or with NSAIDs. Triptans are a major step foreward in migraine therapy. The therapeutic gain for headache relief is 50% for subcutaneous sumatriptan whereas it is 30-40% for most oral triptans. After oral triptans sustained pain free is only 30%. There is thus still ample room for improvement of acute therapy in migraine. For tension-type headache there is no specific therapy and it is treated with NSAIDs. Only 17-32% become pain free after these drugs. For attacks of cluster headache oxygen and subcutaneous sumatriptan can be used. Intranasal triptans can be an alternative. Springer-Verlag 2007-05-11 2007-04 /pmc/articles/PMC3476138/ /pubmed/17497267 http://dx.doi.org/10.1007/s10194-007-0373-z Text en © Springer-Verlag Italia 2007 |
spellingShingle | Tutorial Tfelt-Hansen, Peer Acute pharmacotherapy of migraine, tension-type headache, and cluster headache |
title | Acute pharmacotherapy of migraine, tension-type headache, and cluster headache |
title_full | Acute pharmacotherapy of migraine, tension-type headache, and cluster headache |
title_fullStr | Acute pharmacotherapy of migraine, tension-type headache, and cluster headache |
title_full_unstemmed | Acute pharmacotherapy of migraine, tension-type headache, and cluster headache |
title_short | Acute pharmacotherapy of migraine, tension-type headache, and cluster headache |
title_sort | acute pharmacotherapy of migraine, tension-type headache, and cluster headache |
topic | Tutorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476138/ https://www.ncbi.nlm.nih.gov/pubmed/17497267 http://dx.doi.org/10.1007/s10194-007-0373-z |
work_keys_str_mv | AT tfelthansenpeer acutepharmacotherapyofmigrainetensiontypeheadacheandclusterheadache |